Raija Kallio

2.3k total citations
26 papers, 657 citations indexed

About

Raija Kallio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Raija Kallio has authored 26 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 10 papers in Gastroenterology. Recurrent topics in Raija Kallio's work include Gastric Cancer Management and Outcomes (11 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Gastrointestinal disorders and treatments (5 papers). Raija Kallio is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Gastrointestinal disorders and treatments (5 papers). Raija Kallio collaborates with scholars based in Finland, Sweden and Germany. Raija Kallio's co-authors include Heikki Joensuu, Eva Wardelmann, Peter Hohenberger, Peter Reichardt, Kirsten Sundby Hall, Annette Reichardt, Hannu Syrjälä, Sebastian Bauer, Mikael Eriksson and Jouni Junnila and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Raija Kallio

24 papers receiving 642 citations

Peers

Countries citing papers authored by Raija Kallio

Since Specialization

Citations

This map shows the geographic impact of Raija Kallio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raija Kallio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raija Kallio more than expected).

Fields of papers citing papers by Raija Kallio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raija Kallio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raija Kallio. The network helps show where Raija Kallio may publish in the future.

Co-authorship network of co-authors of Raija Kallio

This figure shows the co-authorship network connecting the top 25 collaborators of Raija Kallio. A scholar is included among the top collaborators of Raija Kallio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raija Kallio. Raija Kallio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol 2025 ·BMC Surgery ·Kristina Hasselgren, Caroline Williamsson, (unknown), Poya Ghorbani, (unknown), Heikki Huhta, Margareta Heby, C. Månsson, Mia Johansson, Nils Elander, (unknown), Raija Kallio, (unknown), Daniel Öhlund, Per Sandström, Ernesto Sparrelid, Bergþór Björnsson	0
2	Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity 2025 ·BMC Immunology ·(unknown), (unknown), Ana Lleò, Luca Di Tommaso, Hannu Raunio, (unknown), Katri Vuopala, (unknown), Sini Nurmenniemi, Raija Kallio, Arja Jukkola‐Vuorinen, Katri S. Selander	1
3	Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial 2024 ·British Journal of Cancer ·Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H. Lindner, Philipp J. Jost, Sebastian Bauer, J. Schütte, S. Lindskog, Raija Kallio, Panu Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt	3
4	607P Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy +/- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy) 2023 ·Annals of Oncology ·Pia Österlund, Emerik Österlund, Päivi Halonen, (unknown), Arno Nordin, (unknown), Tapio Salminen, (unknown), Serge Aho, Annika Ålgars, Raija Ristamäki, Eetu Heervä, Raija Kallio, Annamarja Lamminmäki, (unknown), Timo Muhonen, Teijo Kuopio, Juha Kononen, Bengt Glimelius, Helena Isoniemi	1
5	KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial 2023 ·Clinical Cancer Research ·Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, (unknown), Silke Cameron, Peter Hohenberger, Harri Sihto, Philipp J. Jost, Lars H. Lindner, Sebastian Bauer, Bengt Nilsson, Raija Kallio, (unknown), Peter Reichardt	13
6	PD-19 Finnish population-based metastatic colorectal cancer data collection study – comparison with the prospective RAXO study 2023 ·Annals of Oncology ·Eetu Heervä, Ari Ristimäki, Soili Kytölä, Päivi Halonen, Leena‐Maija Soveri, Tapio Salminen, Annika Ålgars, Raija Ristamäki, (unknown), Annamarja Lamminmäki, Raija Kallio, Arno Nordin, (unknown), Emerik Österlund, Timo Muhonen, Teijo Kuopio, Bengt Glimelius, Helena Isoniemi, Pia Österlund	0
7	Impact of cholangitis on survival of patients with malignant biliary obstruction treated with percutaneous transhepatic biliary drainage 2023 ·BMC Gastroenterology ·(unknown), Raija Kallio, Pasi Ohtonen, Juha Saarnio, Hannu Syrjälä	1
8	Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up. 2020 ·Journal of Clinical Oncology ·Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Bárbara Hermes, Jochen Schuette, Silke Cameron, Peter Hohenberger, Philipp J. Jost, Salah‐Eddin Al‐Batran, Lars H. Lindner, Sebastian Bauer, Eva Wardelmann, (unknown), Raija Kallio, Panu Jaakkola, Jouni Junnila, Thor Alvegård, Peter Reichardt	5
9	Feasibility of switching to S-1 after other fluoropyrimidine-related cardiotoxicity during chemotherapy for solid tumors. 2020 ·Journal of Clinical Oncology ·Pia Österlund, (unknown), Päivi Halonen, Leena‐Maija Soveri, Johannes J.M. Kwakman, Tapio Salminen, Ray McDermott, Per Pfeiffer, Eetu Heervä, Gábor Liposits, (unknown), Annika Ålgars, Raija Kallio, Halfdan Sørbye, Petra Flygare, Helga Hagman, (unknown), Erik van Werkhoven, Bengt Glimelius, Cornelis J.A. Punt, (unknown)	2
10	Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer 2017 ·Supportive Care in Cancer ·Eija Korkeila, Tapio Salminen, Raija Kallio, (unknown), Päivi Auvinen, Seppo Pyrhönen, Raija Ristamäki	5
11	Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort 2016 ·Cancer Research ·Renée T. Fortner, Helena Schöck, Rudolf Kaaks, Matti Lehtinen, Eero Pukkala, (unknown), Minna Tanner, Raija Kallio, Heikki Joensuu, (unknown), Adetunji T. Toriola, Göran Hallmans, Kjell Grankvist, Anne Zeleniuch‐Jacquotte, Paolo Toniolo, Eva Lundin, Heljä‐Marja Surcel	7
12	Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial 2015 ·Journal of Clinical Oncology ·Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Jörg T. Hartmann, Daniel Pink, Giuliano Ramadori, Peter Hohenberger, Salah‐Eddin Al‐Batran, M. Schlemmer, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Harri Sihto, Petri Bono, Raija Kallio, Jouni Junnila, Thor Alvegård, Peter Reichardt	149
13	Three vs. 1 year of adjuvant imatinib (IM) for operable high-risk GIST: The second planned analysis of the randomized SSGXVIII/AIO trial. 2015 ·Journal of Clinical Oncology ·Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Giuliano Ramadori, Peter Hohenberger, Salah‐Eddin Al‐Batran, M. Schlemmer, Sebastian Bauer, Daniel Pink, Justus Duyster, (unknown), Odd R. Monge, Raija Kallio, Petri Bono, Jouni Junnila, Eva Wardelmann, Thor Alvegård, Peter Reichardt	8
14	Early Pregnancy Sex Steroids and Maternal Breast Cancer: A Nested Case–Control Study 2014 ·Cancer Research ·Renée T. Fortner, Helena Schöck, Rudolf Kaaks, Matti Lehtinen, Eero Pukkala, Hans‐Åke Lakso, Minna Tanner, Raija Kallio, Heikki Joensuu, Kjell Grankvist, Anne Zeleniuch‐Jacquotte, Paolo Toniolo, Eva Lundin, Heljä‐Marja Surcel	14
15	Expression of CD11b/CD18 adhesion molecules on circulating phagocytes—a novel aid to diagnose infection in patients with cancer 2008 ·Supportive Care in Cancer ·Raija Kallio, (unknown), A. Takala, Pasi Ohtonen, Juhani Collan, Sanna Siitonen, Heikki Joensuu, Hannu Syrjälä, Heikki Repo	6
16	PERIPHERAL MONONUCLEAR CELL IL-10 AND IL-12 PRODUCTION IS NOT IMPAIRED IN PATIENTS WITH ADVANCED CANCER AND SEVERE INFECTION 2002 ·Cytokine ·Raija Kallio, Heljä‐Marja Surcel, Hannu Syrjälä	6
17	ADMISSION NEOPTERIN AND INTERLEUKIN 12 CONCENTRATIONS IN IDENTIFYING INFECTIONS IN ADULT CANCER PATIENTS 2001 ·Cytokine ·Raija Kallio, Heljä‐Marja Surcel, Aini Bloigu, Hannu Syrjälä	4
18	C-Reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas 2001 ·Supportive Care in Cancer ·Raija Kallio, Aini Bloigu, Heljä‐Marja Surcel, Hannu Syrjälä	29
19	C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients 2000 ·European Journal of Cancer ·Raija Kallio, Heljä‐Marja Surcel, Aini Bloigu, Hannu Syrjälä	51
20	Traditional and new markers of infection in adult cancer patients and the possible interfering effect of underlying malignancy on these markers 2000 ·Raija Kallio	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact